-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637.O2.6 637. Myelodysplastic Syndromes—Clinical Studies: Personalized Clinical-Decision Tools and treatment of lower risk MDS

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, ALL, Follicular Lymphoma, multiple myeloma, CLL, Diseases, Marginal Zone Lymphoma, Non-Biological, smoldering myeloma, Bone Marrow Failure, CMML, Elderly, LGLL, Mantle Cell Lymphoma, Therapies, chemotherapy, CNS Lymphoma, MDS, DLBCL, MPN, Technology and Procedures, Study Population, Clinically relevant, Myeloid Malignancies, molecular testing, NGS
Monday, December 7, 2020: 7:00 AM-8:30 AM
Moderators:
Ellen Ritchie, MD , Weill Cornell Medical College New York Presbyterian and Lionel Ades, MD, PhD, Hopital Saint Louis
Disclosures:
No relevant conflicts of interest to declare.
7:00 AM

Félix López Cadenas, MD1*, Eva Lumbreras2*, Blanca Xicoy, MD3*, Joaquín Sánchez, MD4*, Rosa Coll, MD5*, Bohrane Slama, MD6*, Jose Angel Hernandez-Rivas, MD, PhD7*, Sylvain Thepot, MD8*, Teresa Bernal, MD, PhD9*, Beatriz Arrizabalaga, MD. PhD10*, Agnès Guerci-Bresler, MD, PhD11*, Guillermo F Sanz, MD, PhD12, Joan Bargay, MD13*, Maria Luz Amigo, MD14*, Raquel de Paz, MD15*, Benet Nomdedeu, MD16*, Aristoteles Giagounidis17, Uwe Platzbecker, MD18, Stefan Wickenhauser19*, Katharina S. Götze20, Ali Arar21*, Jesus María Hernández Rivas, MD, PhD22,23, Pierre Fenaux, MD, PhD24, Consuelo Del Cañizo, MD, PhD25 and Maria Diez-Campelo, MD, PhD26,27*

1Hematology Department, Hospital Clínico Universitario de Salamanca, Salamanca, SALAMANCA, Spain
2Department of Hematology, Hospital Universitario de Salamanca, Spain, Salamanca, Spain
3Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol; Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain
4Hematology, University Hospital Reina Sofía, Córdoba, Cordoba, Spain
5Hematology Department, ICO - Hospital Doctor Josep Trueta, Girona, Spain
6Oncologie Médicale-Hématologie Clinique, Centre Hospitalier Departemental, Avignon, France
7University Hospital Infanta Leonor, Madrid, Spain
8Clinical Hematology, Angers University Hospital, Angers, France
9Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
10Department of Hematology, Hospital Universitario Cruces, Vizcaya, Spain
11Service d'Hématologie, Centre Hospitalier Universtaire Brabois, Vandoeuvre-lès-Nancy, France
12Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain
13Department of Hematology, Son Llatzer University Hospital/ IdISBa, Palma de Mallorca, Spain
14Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, Murcia, ESP
15Hematology Department, Hospital Universitario La Paz-Idipaz, Madrid, Spain
16Hematology Department, Hospital Clinic i Provincial de Barcelona, Barcelona, Spain
17Department of Oncology, Hematology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
18Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
19HôPital Caremeau, Nimes Cedex 9, FRA
20Department of Medicine III, Technical University of Munich, Munich, Germany
21Centre Hospitalier Régional d’Orléans, Orleans, FRA
22University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain
23Department of Hematology, University Hospital of Salamanca, Salamanca, Spain
24Hôpital Saint-Louis, Paris, France
25Departamento de Hematología, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
26Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain
27Grupo Español de Síndromes Mielodisplásicos (GESMD), salamanca, salamanca, Spain

7:15 AM

Soo Park, MD1, Brian M Reilly, BS2, Timothy Luger3*, Dan Zhao4*, Robert J. Fram, MD5, Ajeeta B Dash, PhD4* and Rafael Bejar, MD, PhD2

1Moores Cancer Center, University of California San Diego, La Jolla
2Moores Cancer Center, University of California, San Diego, La Jolla, CA
3Arcturus Therapeutics, San Diego, CA
4Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
5Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Needham, MA

7:30 AM

Constance Baer, PhD, Anna Stengel, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD and Torsten Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

7:45 AM

Lin-Pierre Zhao, MD1,2*, Maxime Boy3*, Celia Azoulay2*, Emmanuelle Clappier, PhD, PharmD4*, Marie Sébert, MD, PhD5,6*, Ludivine Amable7*, Jihene Klibi7*, Kamel Benlagha8*, Marion Espeli9,10*, Karl Balabanian11*, Claude Preudhomme, MD, PhD12,13, Alice Marceau14*, Raphael Itzykson, MD, PhD15,16, Arsène Mékinian17*, Olivier Fain, M.D18*, Antoine Toubert19*, Pierre Fenaux, MD, PhD20, Nicolas Dulphy10,21* and Lionel Ades, MD, PhD22

1Université de Paris, Department of Hematology, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
2Université de Paris, Saint Louis Research Institute, EMiLy, Inserm U1160, Paris, France
3Université De Paris, IRSL, Emily, Inserm U1160, Paris, FRA
4Hematology Laboratory, Saint Louis Hospital, AP-HP, Paris, France
5Hématologie clinique, Hôpital Saint-Louis, Paris, France
6Hematology Laboratory and INSERM U944, Hopital Saint-Louis, Paris, France
7Université De Paris, IRSL, Inserm U1160, Paris, FRA
8Université de Paris, Saint Louis Research Institute, Inserm U1160, Paris, France
9University of Paris, Saint Louis Research Institue, EMiLy, Inserm U1160, Paris, FRA
10University of Paris, Saint Louis Research Institue, EMiLy, Inserm U1160, Paris, France
11Université de Paris, Saint Louis Research Institute, EMiLy, Inserm U1160, Paris, FRA
12Laboratory of Hematology, Centre Hospitalier Universitaire Lille, Lille, France
13UMR-S 1172, INSERM, Lille, France
14Molecular Biology, CHRU de Lille, Lille, France
15Hematology Department, Saint-Louis Hospital AP-HP Paris France, Paris, France
16INSERM U944, Institut Universitaire d'Hématologie, Hopital Saint-Louis, Paris, France
17APHP, Hôpital Saint Antoine, Service d'Hématologie Clinique et de Thérapie cellulaire, Paris, France
18Internal Medicine, Saint Antoine University Hospital, université Paris-Sorbonne, Paris, France
19University of Paris, Saint Louis Research Institute, EMiLy, Inserm U1160, PARIS, FRA
20Service d’Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris and Université Paris 7, Paris, France
21Service d'Immunologie et Histocompatibilité / UMRS-1160 INSERM Institut Universitaire d'Hématologie,, Hopital Saint-Louis, Paris, France
22Institut Univeristaire d'Hematologie, Hopital Saint Louis, Paris, France

8:00 AM

Johannes B Goll, MSc1*, Travis L Jensen, BS1*, R. Coleman Lindsley, MD, PhD2, Rafael Bejar, MD, PhD3, Jason Walker4*, Robert Fulton, MS5*, Gregory A. Abel, MD, MPH6, Tareq Al Baghdadi, MD7*, H. Joachim Deeg, MD8, Amy E. DeZern, MD9, Benjamin L. Ebert, MD, PhD10, James M. Foran, MD11, Edward J. Gorak, DO, MBA, MS12, Steven D. Gore, MD13, Rami Komrokji, MD14, Jane Jijun Liu, MD15*, Jaroslaw P. Maciejewski, MD, PhD16,17, Eric Padron, MD18, Wael Saber, MD, MS19, Daniel Starczynowski, PhD20, Myron Waclawiw, PhD21*, Steffanie H. Wilson, PhD1*, Donnie Hebert, PhD22*, Harrison Reed, MSc1*, Nancy L. DiFronzo, PhD21*, Mikkael A. Sekeres, MD, MS23, Alexandra M. Harrington, MD, MT(ASCP)24, Steven H. Kroft, MD25*, Ling Zhang, MD26* and Matthew J. Walter, MD27

1The Emmes Company, LLC, Rockville, MD
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Moores Cancer Center, University of California, San Diego, La Jolla, CA
4Washington University School of Medicine, St. Louis, MO
5McDonnell Genome Institute, Washington University School of Medicine, Saint Louis, MO
6Dana-Farber Cancer Institute, Boston, MA
7IHA Hematology Oncology Consultants, Ypsilanti, MI
8Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
9Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
10Division of Hematology, Harvard Medical School, Boston, MA
11Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
12Baptist MD Anderson Cancer Center, Jacksonville, FL
13National Institutes of Health, National Cancer Institute, Rockville, MD
14H. Lee Moffitt Cancer Center, Tampa, FL
15Illinois Cancer Care, P.C., Peoria, IL
16Cleveland Clinic Main Campus, Department of Hematology/Oncology, Cleveland, OH
17Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
18Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
19CIBMTR, Medical College of Wisconsin, Milwaukee, WI
20Cincinnati Children's Hospital Medical Center, Cincinnati, OH
21National Heart, Lung, and Blood Institute, National Institutes of Health, Division of Blood Diseases & Resources, Bethesda, MD
22The Emmes Company, LLC, Hamburg, NY
23Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
24Medical College of Wisconsin, Milwaukee, WI
25Department of Pathology, Medical College of Wisconsin, Milwaukee, WI
26Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
27Department of Medicine, Division of Oncology, Washington University In St. Louis, Saint Louis, MO

8:15 AM

Nathan Radakovich, BA1*, Manja Meggendorfer, PhD2, Luca Malcovati, MD3, Mikkael A. Sekeres4, Jacob Shreve, MD, MS5*, Cameron Beau Hilton, MD6, Yazan Rouphail7*, Wencke Walter, PhD8*, Stephan Hutter, PhD8*, Sudipto Mukherjee, MD, PhD, MPH9, Cassandra M. Kerr, MS10*, Babal K. Jha, PhD11*, Anna Gallì12*, Sarah Pozzi13*, Aaron T. Gerds, MD, MS14, Cassandra M Kerr, MS11*, Claudia Haferlach, MD15, Jaroslaw P. Maciejewski, MD, PhD10, Torsten Haferlach, MD16 and Aziz Nazha, MD17

1Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
2MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
3Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Piazzale Golgi 2, Pavia, Italy
4Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
5Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
6Department of Internal Medicine, Vanderbilt University, Nashville, TN
7Ohio State University, Rocky River, OH
8MLL Munich Leukemia Laboratory, Munich, Germany
9Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
10Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
11Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
12Department of Hematology Oncology, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
13Centro Cellule Staminali E Terapia Cellulare, Genova, ITA
14Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
15MLL Munich Leukemia Laboratory, Inning am Ammersee, Germany
16MLL Munchner Leukamie Labor Gmbh, Munchen, Germany
17Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Quantitative Health Sciences, Avon Lake, OH

*signifies non-member of ASH